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Introduction Methodology 
 
 
 
 
Reverse logistics is the process of logistics 
management involved in planning, 
management and controlling the flow of 
wastes for either reuse, recycle or final 
disposal of wastage (Hu, Sheu, & Huang, 
2002).  
 
End-of-life (EOL) pharmaceutical 
products are also subject to reuse, 
recycling, storage and/or proper disposal. 
Majority of such EOL products are toxic 
to plants and animals.  
 
Healthcare Distribution Management 
Association (HDMA) estimates three to 
four percent of product going out from 
pharmaceutical warehouses ultimately 
comes back and redistributed, recycled 
and return for disposition.  
 
Firms those invest in information 
technology to increase the capabilities 
may end up with high performance 
efficiency. 
 
This study considers the Food and Drug 
Administration (FDA) rules and 
regulations released regarding EOL and 
counterfeit medications all over United 
States with the intention of implementing 
reverse logistics. 
IT Infrastructure 
Figure 3. Dataflow Diagram of Inspection Process 
The study portrays a composite model of various 
phases such as of forward supply chain, decision input 
to reverse logistics and reverse logistic of EOL 
medications as shown in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Decision input phase emphasizes on: 
Uncontrollable factors:   
 Demand forecasting  
 Government regulations  
 
Controllable factors :  
 Financial goals : Study cost benefit analysis 
 Performance goals :  Reduce significant amount of 
time delay, poor information flow and more number of 
handlers in entire logistics process of medications 
 Environmental goals : Study various existing 
methods (both proper and improper) to dispose EOL 
pharmaceutical products. 
 
Constraints : 
 Physical Constraints:   Inventory Capacity 
 Environmental Constraints: Restriction on amount 
of disposal   and recycling allowed 
 Financial Constraints:  Cost involved in overall 
reverse logistics 
 
Targets: 
 Performance: increase the level of customer 
satisfaction 
 Environmental: increase environmental benefits.  
 Financial: Revenue and profit generated from 
reselling and recycling of the expired drugs 
 
The proposed system mainly partitioned into two main 
processes:  
1) Collection process : Includes ‘Drug Take Back’ 
program. 
2) Inspection Process : Includes validation and 
toxication of EOL medications by performing 
various stability chemical tests.  
The paper put forward the solution using information 
technology software. The use of information technology 
enables companies to improve the profitability by eliminating 
poor information flow and manual mistakes, increasing labor 
productivity and  resource utilization in supply chain. 
 
Role of Information Technology 
 
The software keeps the track of medications using : 
 Barcode Technology 
 Information Database 
 
Classification of EOL medications based on : 
 Expiration date 
 Toxication 
 
Test Cases:  
 Unexpired Drugs  
 Expired and Nontoxic Drugs 
 Expired and Toxic Drugs  
 Damaged Drugs 
 
Result: 
 Redistribution 
 Recycle  
 Dispose 
 
Figure 3 illustrate dataflow diagram of inspection process in 
detail. 
Abstract 
As an attempt to minimize the environmental damage, the number of counterfeit medications, the potential hazard to human health, this study presents a 
framework for managing end-of-life pharmaceutical products. Establishing such an infrastructure capable of conducting proper EOL processing options 
would have numerous advantages when the environment, public health, and financial benefits are considered. Furthermore, a framework that includes 
environmental, economical and physical concerns for the reverse logistics operations of pharmaceutical products is proposed. Required Information 
Technology (IT) infrastructure is also provided. 
Acknowledgement and In Memoriam: This poster is dedicated to the memory of Katherine (Kay) Larobina Macari. This work has been 
inspired by her courage and strength of character. The authors would like to acknowledge the contribution of Dr. Jani Macari Pallis, who posed 
the initial problem. 
References: 
Hu, T.-L., Sheu, J.-B., & Huang, K.-H. (2002). A reverse logistics cost minimization model for the treatment of hazardous wastes. 
Transportation Research Part E: Logistics and Transportation Review, 38(6), 457-473. 
Kongar, E., & Gupta, S. M. (2009). Solving the Disassembly-To-Order Problem Using Linear Physical Programming. International Journal of 
Mathematics in Operational Research (IJMOR), 1(4), 504-531. 
Cost Benefit Analysis: 
 
 Cost Benefit in Credit System 
 Cost Benefit in Redistribution  
 Effective Process Management lower operation cost 
Conclusion and Future Research 
Conclusion: 
 Implement reverse logistics of pharmaceutical products. 
 The effective use of technology, government programs 
facilitate companies to decrease the overall cost or even to 
create financially profitable system. 
 
 Future Research:   
 Putting barcodes on interior packaging of the 
pharmaceutical products 
 Government of United States of America needs work on 
drug recycling laws. 
Figure 2. Work Flow Diagram presents forward and reverse 
logistics of Pharmaceutical Products. 
Adopted from: (Kongar & Gupta, 2009) 
Developed Laws for Drug Recycling 
Under Developed Laws for Drug Recycling 
No Laws for Drug Recycling 
Legend 
Figure 1. FDA drug recycling laws in the US 
National Review 
Figure 1 depicts FDA laws contribution of 
United States of America in drug recycling 
process. 
All states in the US have developed rules 
and regulations for drug recycling except 
the states of North Carolina, South 
Carolina and Oregon.  
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